Question 1

Who are the top researchers at Zogenix (United States)?

Accepted Answer

Ranked on the quality score, Gail M. Farfel lead among researchers whose main affiliation is Zogenix (United States).

Question 2

What are the most cited papers from Zogenix (United States)?

Accepted Answer

The most cited paper from Zogenix (United States) is "Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial" (Lieven G. Lagae, Joseph E. Sullivan, Kelly G. Knupp et al., 2019), with 381 citations. Next come "Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens" (251) and "Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome" (136).

Question 3

Which research topics does Zogenix (United States) publish most on?

Accepted Answer

By volume in 2022-now: Epilepsy research and treatment, Pharmacological Effects and Toxicity Studies, Drug Transport and Resistance Mechanisms and Neuroscience and Neuropharmacology Research.

Question 4

Which keywords describe research at Zogenix (United States)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Antiepileptic Drugs, Inflammation, Surgery, Genetics, Classification, Epilepsy, Neurobiology and Seizures.

Question 5

Which fields of science does Zogenix (United States) work in?

Accepted Answer

In all years, 55% of research at Zogenix (United States) is in Health Sciences, 19% in Physical Sciences. Its largest fields are Medicine (55%), Biochemistry, Genetics and Molecular Biology (10%), Engineering (7%). It does 1.9× the world's share of Health Sciences.

Question 6

Is Zogenix (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 56% lower than in 2018-2021.